|Articles|November 1, 2002
Changing of guard: CIBA Vision successor takes reins as CEO retires
Atlanta-Glen Bradley will retire as chief executive officer of CIBA Vision in early 2003 after more than 30 years of service with affiliated Novartis Corp. companies.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Nanoscope Therapeutics releases positive long-term safety results from EXTEND study
2
Avisi Technologies releases positive 12-month data from VITA Trial
3
Ocular Therapeutix reaches target enrollment of 555 patients in SOL-R trial
4
Sydnexis reports positive phase 3 results for SYD-101 in pediatric myopia
5














































.png)


